Actively Recruiting
The Effects of Laughter Yoga and Mindfulness-Based Stress Reduction on Anxiety, Depression, Quality of Life, and Spiritual Well-being in Women With Breast Cancer Receiving Chemotherapy
Led by Kafkas University · Updated on 2024-08-14
105
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Breast cancer is one of the most common and deadly cancers among women worldwide, with a high frequency especially in women aged 45 to 54. Chemotherapy, a common treatment for breast cancer, can cause significant side effects such as pain, nausea, fatigue, anxiety, and depression, which may reduce patients' quality of life. This research aims to compare the effects of laughter yoga and mindfulness-based stress reduction (MBSR) on anxiety, depression, quality of life, and spiritual well-being in women receiving chemotherapy for breast cancer. Women participating in this study will be randomly assigned to one of three groups: a laughter yoga group, a mindfulness therapy group, or a control group receiving standard hospital care. Both the laughter yoga and mindfulness therapy groups will attend sessions twice a week for 8 weeks, each lasting 40 to 60 minutes. The 9th and 16th sessions will be held face to face during chemotherapy treatment, while other sessions will be conducted online by smartphone at mutually convenient times. After 12 weeks, all groups will complete follow-up assessments. Participants will undergo evaluations using the Hospital Anxiety and Depression Scale to measure anxiety and depression symptoms, the European Organization for Research and Treatment of Cancer Quality of Life Scale to assess quality of life, and a Spiritual Well-being Scale to evaluate spiritual health. Assessments will be completed at the 4th and 8th weeks during face-to-face meetings and again at 12 weeks. The study includes monitoring adherence and excludes participants who cannot attend at least 80% of sessions. The total study duration for participants is approximately 12 weeks.
CONDITIONS
Brief Title
The Effects of Laughter Yoga and Mindfulness-Based Stress Reduction (MBSR) Practices Applied to Women With Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 18 to 60 years
- Diagnosed with stage 1 or stage 2 breast cancer
- Receiving chemotherapy at least once a month and will continue during the study
- Able to communicate and use a smartphone with internet access for group sessions
- Within the first year of chemotherapy treatment (number of cycles)
- Hospital Anxiety and Depression Scale score of 8 or higher
You will not qualify if you...
- Women who do not meet inclusion criteria or refuse to participate
- Participation in less than 80% of study sessions
- Current use of mindfulness therapy, laughter therapy, or complementary medicine outside the study
- Diagnosed psychological disorders
- Metastasis or recurrence of cancer
- Chemotherapy terminated before study completion
- Stage 3 or stage 4 breast cancer
- Receiving chemotherapy for more than one year
- Hospital Anxiety and Depression Scale score of 8 or below
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 8 weeks
Participants receive either laughter yoga or mindfulness-based stress reduction therapy twice a week for 8 weeks during their chemotherapy sessions. Some sessions are held face to face during chemotherapy treatments, while others are conducted online at a time convenient for participants.
Twice-weekly sessions with 2 face-to-face visits during chemotherapy
Duration - 4 weeks
Participants complete additional assessments 4 weeks after the treatment ends to evaluate anxiety, depression, quality of life, and spiritual well-being.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
Hatay Iskenderun State Hospital
İskenderun, Hatay, Turkey (Türkiye)
Actively Recruiting
Research Team
Z
Zehra Coktay, phd stu
R
Rukiye Turk Delibalta, assoc prof
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here